Diacerein or rhein topical formulations and uses thereof
CN110191710A
For preventing or treating the dermopathic method of immunoinflammatory and pharmaceutical composition
US2018021290A1
Diacerein or Rhein topical formulations and uses thereof
TW201739448A
Methods and formulations for treatment and/or prevention of blood-associated disorders
BR112018003212A2
diacerein or analogues thereof to inhibit asc expression, nlrp3 expression and / or inflammasome nlrp3 complex formation
CN107921013A
Diacerein or Rhein topical preparation and application thereof
CN107921284A
The therapeutical uses of barberry alkali preparation
US2016263092A1
Therapeutic uses of berberine formulations
TW201637650A
Formulations containing diacerein and methods of lowering blood levels of uric acid using the same
US2016303050A1
Formulations containing diacerein and methods of lowering blood levels of uric acid using the same
CN107708681A
Preparation containing diacerein and the method using its reduction uric acid blood level
TW201538156A
Berberine formulations and uses thereof
TW201304769A
Pharmaceutical compositions of decreasing glycosylated hemoglobin in patients with dyslipidemia
BR112013022332A2
methods for treating and / or preventing hyperuricemia or a metabolic disorder associated with hyperuricemia, and for improving the control of blood uric acid level; and, pharmaceutical composition.
AU2011237600A1
Methods of using diacerein as an adjunctive therapy for diabetes
EP2467161A1
Methods for diagnosing diabetes and determining effectiveness of treatments
